The classification of abnormal body fluids and the rule of medication in chronic cervicitis in Uyghur medicine
慢性宫颈炎的维吾尔医异常体液分型及用药规律分析

摘要

目的 探讨慢性宫颈炎的维吾尔医异常体液分型并对其用药规律进行分析。方法 现随机选取2022年6月-2023年6月期间就诊于我院确诊并治疗的慢性宫颈炎患者作为本次研究对象，共计纳入120例。按照维吾尔医异常体液分型标准对120例患者进行异常体液证进行辩证分型，同时对现有维吾尔医学有记载的40首治疗慢性宫颈炎治疗的维吾尔医复方进行分析，观察其用药规律。结果 入组参与研究的120例患者中，蓝色胆液质42例（35%），涩味粘液质36例（30%），烧焦沉液质 30例（25.0），腐败的血液质12例（10%）。其中以蓝色胆液质和涩味粘液质居多，二者之间无统计学差异（P＞0.05）。但二者分别与烧焦沉液质和腐败的血液质之间存在统计学意义（P＜0.05）。对40首维吾尔医学治疗慢性宫颈炎分析，供涉及到85中，共计用药410次。其中以收敛燥湿药、消炎药和清除粘液质药物为主，应用频率较高的药物有甘草、洋甘菊、玫瑰花、地锦草、黄诃子和毛诃子。结论 慢性宫颈炎的维吾尔医学异常体液分型以蓝色胆液质和涩味粘液质居多，在用药方面则以收敛燥湿药、消炎药和清除粘液质药物为主。

Abstract

Objective To investigate the abnormal fluid classification of chronic cervicitis and analyze the medicine pattern.
Methods Patients with chronic cervicitis who were diagnosed and treated in our hospital from June 2022 to June 2023 were randomly selected as the subjects of this study, and a total of 120 cases were included. According to the abnormal fluid classification standard of Uyghur medicine, 120 patients with abnormal fluid syndrome were dialectically typed. At the same time, the 40 combinations of chronic cervicitis were analyzed, and the medication rules were observed.
Results Of the 120 patients enrolled in the study, 42 (35%) were blue bile fluid, 36 (30%), 30 (25.0), and 12 (10%). Among them, blue bile fluid quality and astringent mucus quality were the majority, and there was no statistical difference between the two (P> 0.05). However, there were significant values between the burnt and corrupt blood matter, respectively (P <0.05). Analysis of 40 Uyghur medical treatment for chronic cervicitis, for 85 were involved, a total of 410 times. Among them, dryness and dampness drugs, anti-inflammatory drugs and mucinous removal drugs are mainly used, and the drugs with high application frequency are licorice, chamomile, rose, brocade grass, yellow and hairy seeds.
Conclusion   The abnormal body fluid classification of chronic cervicitis is mainly blue bile fluid and astringent mucous, while the convergence of wet drugs, anti-inflammatory drugs and mucinous removal drugs.